Gemmer Asset Management’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-189
| Closed | -$6K | – | 187 |
|
|
2022
Q1 | $6K | Hold |
189
| – | – | ﹤0.01% | 858 |
|
|
2021
Q4 | $7K | Hold |
189
| – | – | ﹤0.01% | 856 |
|
|
2021
Q3 | $6K | Buy |
189
+82
| +77% | +$2.6K | ﹤0.01% | 873 |
|
|
2021
Q2 | $4K | Hold |
107
| – | – | ﹤0.01% | 1149 |
|
|
2021
Q1 | $5K | Hold |
107
| – | – | ﹤0.01% | 1029 |
|
|
2020
Q4 | $5K | Hold |
107
| – | – | ﹤0.01% | 954 |
|
|
2020
Q3 | $4K | Hold |
107
| – | – | ﹤0.01% | 930 |
|
|
2020
Q2 | $3K | Hold |
107
| – | – | ﹤0.01% | 1019 |
|
|
2020
Q1 | $3K | Sell |
107
-122
| -53% | -$3.42K | ﹤0.01% | 920 |
|
|
2019
Q4 | $8K | Sell |
229
-1
| -0.4% | -$35 | ﹤0.01% | 724 |
|
|
2019
Q3 | $9K | Buy |
230
+1
| +0.4% | +$39 | ﹤0.01% | 685 |
|
|
2019
Q2 | $10K | Sell |
229
-19
| -8% | -$830 | ﹤0.01% | 635 |
|
|
2019
Q1 | $11K | Hold |
248
| – | – | ﹤0.01% | 631 |
|
|
2018
Q4 | $11K | Hold |
248
| – | – | ﹤0.01% | 566 |
|
|
2018
Q3 | $17K | Hold |
248
| – | – | 0.01% | 453 |
|
|
2018
Q2 | $14K | Hold |
248
| – | – | ﹤0.01% | 537 |
|
|
2018
Q1 | $11K | Hold |
248
| – | – | ﹤0.01% | 633 |
|
|
2017
Q4 | $11K | Hold |
248
| – | – | ﹤0.01% | 649 |
|
|
2017
Q3 | $11K | Hold |
248
| – | – | ﹤0.01% | 609 |
|
|
2017
Q2 | $10K | Hold |
248
| – | – | ﹤0.01% | 627 |
|
|
2017
Q1 | $9K | Hold |
248
| – | – | ﹤0.01% | 676 |
|
|
2016
Q4 | $9K | Hold |
248
| – | – | ﹤0.01% | 641 |
|
|
2016
Q3 | $9K | Hold |
248
| – | – | ﹤0.01% | 630 |
|
|
2016
Q2 | $8K | Buy |
248
+31
| +14% | +$1K | ﹤0.01% | 641 |
|
|
2016
Q1 | $6K | Buy |
217
+16
| +8% | +$442 | ﹤0.01% | 736 |
|
|
2015
Q4 | $7K | Buy |
201
+87
| +76% | +$3.03K | ﹤0.01% | 668 |
|
|
2015
Q3 | $3K | Sell |
114
-21
| -16% | -$553 | ﹤0.01% | 951 |
|
|
2015
Q2 | $5K | Sell |
135
-19
| -12% | -$704 | ﹤0.01% | 824 |
|
|
2015
Q1 | $8K | Buy |
154
+32
| +26% | +$1.66K | ﹤0.01% | 696 |
|
|
2014
Q4 | $6K | Buy |
+122
| New | +$6K | ﹤0.01% | 771 |
|